Skip to main content
Premium Trial:

Request an Annual Quote

Gotcha!: Jul 6, 2012


Cornell University's Brian Kirby and his colleagues reported on their development of a 'sticky' silicon chip known as geometrically enhanced differential immunocapture, or GEDI, in PLoS One in April. Now, Kirby tells the Cornell Chronicle, the researchers are applying this new cell-capture device to trap circulating tumor cells in blood samples from patients with metastatic cancers.

"Most cancer cells are bigger and more rigid than normal cells, so it's about tricking these cancer cells into colliding with the sticky walls," Kirby tells the Cornell Chronicle. The paper adds that the GEDI device is slated to go to clinical trial this year, and the Kirby and his colleagues "are actively working on detectors for breast, ovarian and pancreatic cancers."

HT: Fierce Health IT

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.